2010
DOI: 10.3171/2010.1.jns09506
|View full text |Cite
|
Sign up to set email alerts
|

Brain tissue oxygen–directed management and outcome in patients with severe traumatic brain injury

Abstract: These results suggest that PbtO(2)-based therapy, particularly when compromised PbtO(2) can be corrected, may be associated with reduced patient mortality and improved patient outcome after severe TBI.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
121
0
1

Year Published

2011
2011
2021
2021

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 216 publications
(127 citation statements)
references
References 57 publications
(94 reference statements)
5
121
0
1
Order By: Relevance
“…Indeed, the use of management schemes that incorporate vigorous CPP augmentation can result in significant cardiorespiratory complications (Robertson et al, 1999). Further, there is accumulating evidence that the optimum level of CPP varies between patients, and the optimum level in a given patient may be identifiable using autoregulatory indices (Howells et al, 2005;Steiner et al, 2002), or brain oximetry (Spiotta et al, 2010).…”
Section: Individualizing Clinical Managementmentioning
confidence: 99%
“…Indeed, the use of management schemes that incorporate vigorous CPP augmentation can result in significant cardiorespiratory complications (Robertson et al, 1999). Further, there is accumulating evidence that the optimum level of CPP varies between patients, and the optimum level in a given patient may be identifiable using autoregulatory indices (Howells et al, 2005;Steiner et al, 2002), or brain oximetry (Spiotta et al, 2010).…”
Section: Individualizing Clinical Managementmentioning
confidence: 99%
“…In observational studies comparing historical cohorts with P btO 2 -managed subjects, data show mortality and functional outcome benefits. [99][100][101] However, many single-center studies have not demonstrated this benefit. In a study with 93 subjects, Meixensberger et al 102 compared P btO 2 -directed therapy with cerebral perfusion pressure-directed therapy and found no difference between groups.…”
Section: Limitationsmentioning
confidence: 99%
“…The current recommendation for a treatment threshold to maintain PbO 2 above 20 mmHg is based on a paucity of outcome data, which include the widespread use of historical controls. This is reflected in the strength of the recommendation for their widespread use [27,28]. More recently a prospectively randomized single-center trial comparing the addition of PbO 2 monitoring and targeted treatment to a protocol based on the established guidelines found no difference in mortality or functional outcome [29].…”
Section: Pbo 2 and Metabolism Monitoringmentioning
confidence: 99%